The novel cyclopropapyrroloindole (CPI) bisalkylators bearing 3,3′-(1,4-phenylene)diacryloyl group as a linker

被引:13
作者
Fukuda, Y [1 ]
Seto, S
Furuta, H
Ebisu, H
Oomori, Y
机构
[1] Kyorin Pharmaceut Co Ltd, Cent Res Labs, Nogi, Tochigi 3290114, Japan
[2] Sagami Chem Res Ctr, Kanagawa 2290012, Japan
关键词
D O I
10.1016/S0960-894X(98)00346-1
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The novel cyclopropapyrroloindole(CPI) bisalkylators were synthesized and their antitumor activity was evaluated. Among these derivatives, AT-760 (5a) in which the two 3-methoxycarbonyl-2-trifluoromethylCPI (MCTFCPI) moieties are connected with a 3,3'-(1,4-phenylene)diacryloyl group, was found to exhibit more prominent cytotoxicity and antitumor activity than U-77,779 (bizelesin) (1). (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2003 / 2004
页数:2
相关论文
共 6 条
[1]   Synthesis and antitumor activity of novel cyclopropapyrroloindole (CPI) derivatives bearing methoxycarbonyl and trifluoromethyl groups [J].
Fukuda, Y ;
Furuta, H ;
Shiga, F ;
Oomori, Y ;
Kusama, Y ;
Ebisu, H ;
Terashima, S .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (13) :1683-1688
[2]   Novel syntheses of optically active CC-1065, U-73,975 (adozelesin), U-80,244 (carzelesin), U-77,779 (bizelesin), KW-2189, and DU-86 [J].
Fukuda, Y ;
Furuta, H ;
Shiga, F ;
Asahina, Y ;
Terashima, S .
HETEROCYCLES, 1997, 45 (12) :2303-2308
[3]   A novel synthesis of (+)-duocarmycin SA [J].
Fukuda, Y ;
Terashima, S .
TETRAHEDRON LETTERS, 1997, 38 (41) :7207-7208
[4]   The novel cyclopropapyrroloindole(CPI) bisalkylators bearing methoxycarbonyl and trifluoromethyl groups [J].
Fukuda, Y ;
Furuta, H ;
Kusama, Y ;
Ebisu, H ;
Oomori, Y ;
Terashima, S .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (11) :1387-1390
[5]  
FUKUDA Y, UNPUB HETEROCYCLES
[6]   SYNTHESIS AND DNA CROSS-LINKING BY A RIGID CPI DIMER [J].
MITCHELL, MA ;
KELLY, RC ;
WICNIENSKI, NA ;
HATZENBUHLER, NT ;
WILLIAMS, MG ;
PETZOLD, GL ;
SLIGHTOM, JL ;
SIEMIENIAK, DR .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1991, 113 (23) :8994-8995